Vipul Pharma Private Limited

Pharmaceutical company providing manufacturing services for pharmaceutical products since 2009.

2009 | Delhi (India) | Active
Last Updated:

Vipul Pharma Profile

Key Indicators

  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 15 Year, 2 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 3.00 Cr
  • Satisfied Charges ₹ 6.50 Cr
  • Revenue Growth -20.39%
  • Profit Growth -52.76%
  • Ebitda -692.86%
  • Net Worth 5.31%
  • Total Assets -32.14%

About Vipul Pharma

Vipul Pharma Private Limited (VPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 16 December 2009 and has a history of 15 years and two months. Its registered office is in Delhi, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.

The company currently has active open charges totaling ₹3.00 Cr. The company has closed loans amounting to ₹6.50 Cr, as per Ministry of Corporate Affairs (MCA) records.

Parvinder Kansal and Sonia Kansal serve as directors at the Company.

Company Details

  • Location

    Delhi, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U24232DL2009PTC196994

  • Company No.

    196994

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    16 Dec 2009

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Delhi

Industry

Pharma

What products or services does Vipul Pharma Private Limited offer?

Vipul Pharma Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Anti Infective Agent, Antifungal Injection, Tablet & Syrup, Brain & Nervous System Drugs, Antiepileptic Drugs, Common Disease Medicines, Psoriasis Ointment, Nutraceuticals & Dietary Supplements, Nutraceuticals, Antibacterial Drugs.

Who are the key members and board of directors at Vipul Pharma?

Board Members (2)

NameDesignationAppointment DateStatus
Parvinder Kansal Country flag representing In Whole-Time Director 16-Dec-2009Current
Sonia Kansal Country flag representing In Whole-Time Director 08-Aug-2017Current

Financial Performance of Vipul Pharma.

Vipul Pharma Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 20.39% decrease. The company also saw a substantial fall in profitability, with a 52.76% decrease in profit. The company's net worth moved up by a moderate rise of 5.31%.

Vipul Pharma revenue growth over time
Vipul Pharma profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-20.39%
Revenue from Operations
-19.73%
Total Assets
-32.14%
Profit or Loss
-52.76%
Net Worth
5.31%
EBITDA
-692.86%

What is the Ownership and Shareholding Structure of Vipul Pharma?

In 2021, Vipul Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹30.00 M

Satisfied Charges

₹65.00 M

Charges Breakdown by Lending Institutions

  • Others : 3.00 Cr

Latest Charge Details

DateLenderAmountStatus
07 Aug 2020Others₹3.00 CrOpen
05 Nov 2018Hdfc Bank Limited₹2.00 CrSatisfied
20 Apr 2017Yes Bank Limited₹3.00 CrSatisfied
21 Jul 2016Indian Bank₹1.50 CrSatisfied

How Many Employees Work at Vipul Pharma?

Unlock and access historical data on people associated with Vipul Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Vipul Pharma Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Vipul Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vipul Pharma's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Vipul Pharma

Recent activity within the organization

  • Annual General Meeting

    Vipul Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

  • Balance Sheet

    Vipul Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.

  • Charges

    A charge with Others amounted to Rs. 30.00 M with Charge ID 100359253 was registered on 07 Aug 2020.

  • Charges

    A charge registered on 20 Apr 2017 via Charge ID 100132022 with Yes Bank Limited was fully satisfied on 11 Jun 2020.

  • Charges

    A charge registered on 05 Nov 2018 via Charge ID 100220944 with Hdfc Bank Limited was fully satisfied on 12 Feb 2020.

  • Charges

    A charge with Yes Bank Limited of Rs. 30.00 M registered on 20 Apr 2017 with Charge ID 100132022 was modified on 16 Feb 2019.

Frequently asked questions

  • What is the Incorporation or founding date of Vipul Pharma Private Limited?

    Vipul Pharma Private Limited was incorporated on 16 Dec 2009.

  • What is authorized share capital and paid-up capital of Vipul Pharma Private Limited?

    The authorized share capital of Vipul Pharma Private Limited is ₹ 0.50 M and paid-up capital is ₹ 0.10 M.

  • Who are the current board members & directors of Vipul Pharma Private Limited?

    Currently 2 directors are associated with Vipul Pharma Private Limited.

    • Parvinder Kansal
    • Sonia Kansal

  • What is the registered address of Vipul Pharma Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Vipul Pharma Private Limited is Unit No.805, Klj Tower Netaji Subhash Place Pitampura India, Delhi, 110034.

  • What is the corporate identification number (CIN) and company number of Vipul Pharma Private Limited?

    The corporate identification number (CIN) of Vipul Pharma Private Limited is U24232DL2009PTC196994 and the company number is 196994 as per Ministry of Corporate Affairs (MCA).

  • What has been the recent revenue trend for Vipul Pharma Private Limited?

    According to the financial reports for the fiscal year 2022, the revenue trend for Vipul Pharma Private Limited has fallen by -20.39%.

  • What change has been observed in the net worth of Vipul Pharma Private Limited, and by what percentage?

    The financial reports for the fiscal year 2022 indicates that The net worth of Vipul Pharma Private Limited has experienced an upsurge of 5.31%.

  • What are the total open charges for Vipul Pharma Private Limited?

    As per the financial statements for fiscal Year 2022, The total open charges for Vipul Pharma Private Limited amount to ₹ 3.00 Cr.

  • When was the last Balance Sheet of Vipul Pharma Private Limited filed with the ROC?

    The most recent Balance Sheet for Vipul Pharma Private Limited was filed with the ROC on 31 Mar 2024.

People also Viewed

Similar Companies Based on Drug Formulation & Development